Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: A cohort analysis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Desai, Shailey S ^a   Myles, James D ^b   Kaplan, Mariana J ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; INSULIN; LEFLUNOMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TRIACYLGLYCEROL; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ETHNICITY; EXERCISE; FAMILY HISTORY; FEMALE; GENDER; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; OBESITY; OUTPATIENT CARE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK MANAGEMENT; SMOKING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CONTROL; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE; RISK FACTORS; SMOKING;

EID: 84870858614     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4118     Document Type: Article

References (27)

1. Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984, 23:92-99. 10.1093/rheumatology/23.2.92, 6722416.
2. Jacobsson LT, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, del Puente A, McCance DR, Charles MA, Bennett PH. Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum 1993, 36:1045-1053. 10.1002/art.1780360804, 8343181.
3. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008, 58:2268-2274. 10.1002/art.23650, 2929699, 18668561.
4. Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 2008, 58:2612-2621. 10.1002/art.23811, 18759273.
5. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732. 10.1002/art.20878, 15751097.
6. Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O'Fallon WM, Gabriel SE. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?. Ann Rheum Dis 2008, 67:64-69. 10.1136/ard.2006.059980, 17517756.
7. Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 2007, 3:845-852. 2350142, 18200805.
8. Gremese E, Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 2011, 10:582-589. 10.1016/j.autrev.2011.04.018, 21539940.
9. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, Hansen PR. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011, 70:929-934. 10.1136/ard.2010.143396, 21389043.
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
11. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo A, Tentolouris N, Mavrikakis M, Sfikakis PP. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol 2009, 29:1702-1708. 10.1161/ATVBAHA.109.190108, 19608975.
12. Executive summary: standards of medical care in diabetes, 2011. Diabetes Care 2011, 34(Suppl 1):S4-S10. 3006058, 21193627.
13. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-331. 10.1136/ard.2009.113696, 19773290.
14. Nguyen-Oghalai TU, Hunnicutt SE, Smith ST, Maganti R, McNearney TA. Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis. J Clin Rheumatol 2007, 13:307-312. 10.1097/RHU.0b013e318156bcc2, 18176137.
15. Bartels CM, Kind AJ, Everett C, Mell M, McBride P, Smith M. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. Arthritis Rheum 2011, 63:1221-1230. 10.1002/art.30239, 3086993, 21305507.
16. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411. 10.1002/art.20853, 15693010.
17. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998, 338:1516-1520. 10.1056/NEJM199805213382106, 9593791.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
19. Standards of medical care in diabetes, 2011. Diabetes Care 2011, 34(Suppl 1):S11-S61. 3006050, 21193625.
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation 2002, 106:3143-3421. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
21. Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009, 61:1571-1579. 10.1002/art.24836, 19877093.
22. Bell C, Rowe IF. The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners. Musculoskel Care 2011, 9:69-74.
23. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012, 110:420-424. 10.1016/j.amjcard.2012.03.044, 22521305.
24. Chung CP, Giles JT, Petri M, Szklo M, Post W, Blumenthal RS, Gelber AC, Ouyang P, Jenny NS, Bathon JM. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012, 41:535-544. 10.1016/j.semarthrit.2011.07.004, 3538033, 22340996.
25. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001, 40:640-644.
26. White D, Fayez S, Doube A. Atherogenic lipid profiles in rheumatoid arthritis. N Z Med J 2006, 119:U2125.
27. McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54:2541-2549. 10.1002/art.21976, 16868975.